MARKER THERAPEUTICS, INC. Derivative Liability, Current
MARKER THERAPEUTICS, INC. (MRKR) had Derivative Liability, Current of $0 as of 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2021-03-09
- 2020-12-31: Derivative Liability, Current $0.00.
- 2020-09-30: Derivative Liability, Current $0.00.
- 2020-03-31: Derivative Liability, Current $0.00.
- 2019-12-31: Derivative Liability, Current $31.00K.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-09 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $31.00K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $129.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $65.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $58.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $49.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $107.00K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $147.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $8.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $9.00K 10-K · filed 2019-03-15 | |
| 2017-09-30 | $6.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $10.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $17.50K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $14.50K 10-K · filed 2018-03-23 | |
| 2016-09-30 | $29.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $21.25M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $29.49M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $26.49M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $32.20M 10-Q/A · filed 2016-04-14 | $7.43M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $69.96M 10-Q/A · filed 2016-04-14 | $11.67M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $8.99M 10-Q/A · filed 2016-04-14 | $2.05M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $9.41K 10-Q/A · filed 2016-04-14 | |
| 2014-03-31 | $603.89K 10-Q/A · filed 2014-05-21 | |
| 2013-12-31 | $140.50K 10-Q/A · filed 2014-05-21 | |
| 2013-09-30 | $89.19K 10-Q · filed 2013-11-19 | |
| 2013-03-31 | $462.29K 10-Q/A · filed 2013-08-19 | |
| 2012-12-31 | $977.09K 10-K/A · filed 2014-04-17 | |
| 2012-06-30 | $894.64K 10-Q/A · filed 2012-09-12 | |
| 2012-03-31 | $1.25M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $1.32M 10-Q/A · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |